JG
MBII

Jefferies Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Jefferies Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-740,000
Closed -$533K – 2100
2021
Q4 		$533K Buy
+740,000
New +$599K ﹤0.01% 1158

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group's MBII Position: Q1 2022 in Review

Jefferies Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 740,000 shares — an estimated $533K sold.

Jefferies Group first reported a position in MBII in Q4 2021 and held it in 1 quarter. The position peaked at $533K in Q4 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Jefferies Group reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 740,000 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $533K.
  • Jefferies Group first reported a position in Marrone Bio Innovations, Inc. in Q4 2021 and held it in 1 quarter.
  • Jefferies Group's Marrone Bio Innovations, Inc. position peaked at $533K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.